Bristol-Myers Squibb Company (BMY) Announces Extension of U.S. Agreement for ABILIFY(R) and Establishment of an Oncology Collaboration with Otsuka America Pharmaceutical, Inc.
4/6/2009 9:53:35 AM
More...
|
Otsuka America Pharmaceutical, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. Announce Restructuring
2/25/2009 7:26:41 AM
More...
|
Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer
2/12/2009 6:52:03 AM
More...
|
Otsuka America Pharmaceutical, Inc. Release: American Psychiatric Association Announces Recipients of 2008 Awards for Advancing Minority Mental Health; Awards Honoring Mental Health Programs Supported by a Grant from Otsuka America Pharmaceutical, Inc.
5/23/2008 2:58:16 PM
More...
|
Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger
10/2/2007 8:59:22 AM
More...
|
EVEREST Data Use of Otsuka America Pharmaceutical, Inc.'s Investigational Novel Treatment, Tolvaptan, Published in Journal of the American Medical Association and Featured in ACC's Late Breaking Clinical Trials
3/26/2007 11:00:52 AM
More...
|
Bristol-Myers Squibb Company (BMY) Release: ABILIFY(R) (Aripiprazole) Injection For Intramuscular Use For Adults With Agitation Associated With Schizophrenia Or Bipolar Mania Now Available
12/12/2006 12:46:50 PM
More...
|
Summit Corporate Services, Inc. To Provide Clinical Trial Monitoring Services For Otsuka America Pharmaceutical, Inc.
10/17/2006 11:56:34 AM
More...
|
FDA Calls For Warning On Antipsychotic Drugs
10/19/2005 5:13:15 PM
More...
|
Hiromi Yoshikawa, Chairman And CEO Of Otsuka America Pharmaceutical, Inc. Joins PhRMA Board Of Directors
10/19/2005 5:13:11 PM
More...
|
|